G Medical Innovations Holdings Ltd

GMVDNASDAQHealthcare

$0.18

+$0.00(+1.38%)

Market Cap$1801155

P/E Ratio—

52W High$13.825

52W Low$0.145

Avg Volume1.3M

Open$0.16

Beta-1.08

Overview

G Medical Innovations Holdings Ltd (GMVD) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

GMVD · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2021Report Date: Jun 28, 2021

EPS Actual

-$98.53

Revenue

$0.01B

Fiscal Period

Q2 FY2021

FY ends December

Report Date

Jun 28, 2021

After Market Close

GMVD reports quarterly as a NASDAQ-listed Medical - Instruments & Supplies company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q2 FY2023	Apr 27, 2023	—	—	—	—	—	—
◌ Q4 FY2022	Nov 18, 2022	—	—	—	—	—	—
◌ Q4 FY2021	Dec 31, 2021	—	—	—	$-0.00B	—	—
◌ Q3 FY2021	Sep 15, 2021	—	—	—	—	—	—
— Q2 FY2021	Jun 28, 2021	—	-$98.53	—	$0.01B	—	—
— Q4 FY2019	Dec 31, 2019	—	-$2.00	—	$0.00B	—	—
— Q2 FY2019	Jun 30, 2019	—	-$1.00	—	$0.00B	—	—
— Q4 FY2018	Dec 31, 2018	—	-$2.51	—	$0.00B	—	—

Q2 FY2023

Apr 27, 2023

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2022

Nov 18, 2022

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q4 FY2021

Dec 31, 2021

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

$-0.00B

Q3 FY2021

Sep 15, 2021

EPS Actual

—

EPS Est.

—

EPS Surpr.

—

Revenue

—

Q2 FY2021

Jun 28, 2021

EPS Actual

-$98.53

EPS Est.

—

EPS Surpr.

—

Revenue

$0.01B

Q4 FY2019

Dec 31, 2019

EPS Actual

-$2.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q2 FY2019

Jun 30, 2019

EPS Actual

-$1.00

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

Q4 FY2018

Dec 31, 2018

EPS Actual

-$2.51

EPS Est.

—

EPS Surpr.

—

Revenue

$0.00B

No analyst estimates available for GMVD.

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
— Q2 FY2021	Jun 28, 2021	—	$120.75	$133.00	+10.14%
— Q4 FY2019	Dec 31, 2019	—	No price data	$120.75	—
— Q2 FY2019	Jun 30, 2019	—	No price data	$120.75	—
— Q4 FY2018	Dec 31, 2018	—	No price data	$120.75	—
— Q2 FY2018	Jun 30, 2018	—	No price data	$120.75	—
— Q4 FY2017	Dec 31, 2017	—	No price data	$120.75	—
— Q2 FY2017	Jun 30, 2017	—	No price data	$120.75	—

Q2 FY2021+10.14%

Report Date

Jun 28, 2021

EPS Beat/Miss

—

Price Before

$120.75

Price After

$133.00

Q4 FY2019—

Report Date

Dec 31, 2019

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Q2 FY2019—

Report Date

Jun 30, 2019

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Q4 FY2018—

Report Date

Dec 31, 2018

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Q2 FY2018—

Report Date

Jun 30, 2018

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Q4 FY2017—

Report Date

Dec 31, 2017

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Q2 FY2017—

Report Date

Jun 30, 2017

EPS Beat/Miss

—

Price Before

—

Price After

$120.75

Beat Rate0 / 7 quarters

Largest Move+10.14% (Q2 FY2021)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

G Medical Innovations Holdings Ltd (GMVD) most recently reported earnings on June 28, 2021 for Q2 FY2021, posting EPS of $-98.53 (in line with the analyst consensus of —). The next GMVD earnings date is expected around September 1, 2026.

Each quarter, investors track GMVD earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. GMVD revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

GMVD's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

GMVD earnings · 4 questions

G Medical Innovations Holdings Ltd's next earnings report is expected around September 1, 2026. GMVD typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; GMVD historically reports after market close (AMC).

GMVD earnings datewhen is GMVD earningsGMVD next earnings datewhen does GMVD report earningsGMVD earnings calendar

▸ Source: FMP · G Medical Innovations Holdings Ltd SEC filings · US GAAP · G Medical Innovations Holdings Ltd SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026